Bayer seeks an incumbent who possesses the following: Required Qualifications: Bachelor's degree required e.g. in business, life sciences, healthcare, pharmacy, public health, medicine, or a related field required; Significant experience in the biopharmaceutical, pharmaceutical, or biotechnology industry in commercial strategy, new product planning, pipeline strategy, portfolio strategy, marketing, consulting, or related functions; Meaningful experience in oncology; Proven success developing commercial strategies for pipeline and/or inline oncology assets; Strong understanding of drug development, commercialization planning, launch strategy, and market access; Experience working in complex, matrixed organizations with global and cross-regional stakeholders; Strong strategic, analytical, and problem-solving capabilities; Excellent communication skills, executive presence, and stakeholder management ability; Demonstrated team leadership and/or success leading through influence at senior levels; Build, coach, and develop high-performing talent; Set clear priorities and elevate strategic thinking across the team; Foster an inclusive environment that welcomes diverse perspectives and constructive challenge; Mentor team members and strengthen organizational capability in oncology pipeline commercial strategy; Lead effectively through influence across functions, markets, and seniority levels; Strategic and enterprise mindset; Strong business acumen and sound judgment; Learning agility and comfort operating in ambiguity; Highly collaborative and effective in matrixed environments; Data-driven and analytically rigorous; Decisive, proactive, and execution-oriented; Strong people leadership and talent development capability; Clear, persuasive communicator; High integrity, accountability, and professionalism; Commitment to patient impact and scientific innovation. Lead commercial assessment of partnering opportunities; Provide strategic commercial input on disease area opportunity, competitive landscape, unmet need, treatment paradigm evolution, patient journey, and market access considerations; Partner closely with R&D, BD&L medical affairs, market access, finance, business development, and regional and local commercial teams to shape development and commercialization plans; Inform key governance decisions through robust commercial assessments, including indication prioritization, lifecycle strategy, portfolio trade-offs, and investment decisions; Define target product profiles, strategic positioning, segmentation approaches, and value proposition frameworks for pipeline assets; Guide insight generation, market research, forecasting assumptions, scenario planning, and opportunity sizing; Ensure commercial perspectives are embedded in milestone decisions from early development through pre-launch planning; Support development of launch strategies and launch readiness plans, including market shaping, stakeholder engagement, access strategy, and organizational preparedness; Drive portfolio prioritization discussions by evaluating commercial attractiveness, strategic fit, competitive intensity, and execution feasibility; Identify strategic risks and opportunities and recommend actions to optimize future asset value.